Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

QCLS

Q/C TECHNOLOGIES, INC.

CIK 0001321834 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$3.72
↑ 0.06 (1.64%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$29.21M
P/E Ratio
-2.49
EPS
-8.66
Dividend Yield
Not covered
52W Position
41%
Beta
2.53

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.41
P/S
Not covered
EV/Revenue
Not covered
ROE
-56.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 41%
$0.04$8.94

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$11.63M
Total Assets
$41.17M
Free Cash Flow
–

Recent news